[daughart]

> Cures don't make profit, treatments do.

This shows that you don't understand the market well.

"Harvoni, made by Gilead Sciences, has cure rates of between 94 and 99 per cent. It is the successor to Gilead’s Sovaldi, which has accrued more than $7bn in US sales since it became available in the final quarter of 2013.

Early data suggest Harvoni is poised to be even more of a success."

http://www.ft.com/cms/s/0/7ac62214-5e1c-11e4-bc04-00144feabd...

Also, the goal of ALL cancer treatments is to cure the cancer (other than maybe slow growing prostate cancers and cancers where there is no cure available and the best you can do is palliative care).